BoulangerE., MoranneO., WautierM.P., Witko-SarsatV., Descamps-LatschaB., KandoussiA.Changes in glycation and oxidation markers in patients starting peritoneal dialysis: a pilot study.Perit Dial Int2006; 26: 207–12.
2.
BaynesJ.W., MonnierV.M.The Maillard reaction in aging, diabetes and nutrition.Prog Clin Biol Res1989; 30-4: 1–410.
3.
BrownleeM., CeramiA., VlassaraH.Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications.N Engl J Med1988; 20: 1315–21.
4.
MakitaZ., RadoffS., RayfieldE.J., YangZ., SkolnikE., DelaneyV.Advanced glycosylation end products in patients with diabetic nephropathy.N Engl J Med1991; 325: 836–42.
5.
SugiyamaS., MiyataT., MaedaK., UedaY., TsuyukiM., TanakaH.Plasma levels of pentosidine in diabetic patients: an advanced glycation end product.J Am Soc Nephrol1998; 9: 1681–8.
6.
MakitaZ., BucalaR., RayfieldE.J., FriedmanE.A., KaufmanA.M., KorbetS.M.Reactive glycosylation endproducts in diabetic uraemia and treatment of renal failure.Lancet1994; 343: 1519–22.
7.
MiyataT., UedaY., YamadaY., SaitoA., JadoulM., van Ypersele de StrihouC.Accumulation of carbonyls accelerates the formation of pentosidine, an advanced glycation end product: carbonyl stress in uremia.J Am Soc Nephrol1998; 9: 2349–56.
8.
MiyataT., KurokawaK., van Ypersele de StrihouC.Advanced glycation and lipoxidation end products: role of reactive carbonyl compounds generated during carbohydrate and lipid metabolism.J Am Soc Nephrol2000; 11: 1744–52.
9.
MiyataT., UedaY., ShinzatoT., IidaY., TanakaS., KurokawaK.Accumulation of albumin-linked and free-form pentosidine in the circulation of uremic patients with end-stage renal failure: renal implications in the pathophysiology of pentosidine.J Am Soc Nephrol1996; 7: 1198–206.
10.
Witko-SarsatV., FriedlanderM., Capeillere-BlandinC., Nguyen-KhoaT., NguyenA.N., ZingraffJ.Advanced oxidation protein products as a novel marker of oxidative stress in uremia.Kidney Int1996; 49: 1304–13.
11.
MiyataT., UedaY., YoshidaA., SugiyamaS., IidaY., JadoulM.Clearance of pentosidine, an advanced glycation end product, by different modalities of renal replacement therapy.Kidney Int1997; 51: 880–7.
12.
SchinzelR., MunchG., HeidlandA., SebekovaK.Advanced glycation end products in end-stage renal disease and their removal.Nephron2001; 87: 295–303.
13.
JadoulM., UedaY., YasudaY., SaitoA., RobertA., IshidaN.Influence of hemodialysis membrane type on pentosidine plasma level, a marker of “carbonyl stress.”Kidney Int1999; 55: 2487–92.
14.
MiyataT., WadaY., CaiZ., IidaY., HorieK., YasudaY.Implication of an increased oxidative stress in the formation of advanced glycation end products in patients with end-stage renal failure.Kidney Int1997; 51: 1170–81.
15.
UedaY., MiyataT., HashimotoT., YamadaH., IzuharaY., SakaiH.Implication of altered redox regulation by anti-oxidant enzymes in the increased plasma pentosidine, an advanced glycation end product, in uremia.Biochem Biophys Res Commun1998; 245: 785–90.
16.
Wells-KnechtM.C., LyonsT.J., McCanceD.R., ThorpeS.R., BaynesJ.W.Age-dependent increase in ortho-tyrosine and methionine sulfoxide in human skin collagen is not accelerated in diabetes. Evidence against a generalized increase in oxidative stress in diabetes.J Clin Invest1997; 100: 839–46.
17.
HorieK., MiyataT., MaedaK., MiyataS., SugiyamaS., SakaiH.Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implication for glycoxidative stress in the pathogenesis of diabetic nephropathy.J Clin Invest1997; 100: 2995–3004.
18.
MiyataT., van Ypersele de StrihouC.Angiotensin II receptor blockers and angiotensin converting enzyme inhibitors: implication of radical scavenging and transition metal chelation in inhibition of advanced glycation end product formation.Arch Biochem Biophys2003; 419: 50–4.
19.
MiyataT., DevuystO., KurokawaK., van Ypersele de StrihouC.Toward better dialysis compatibility: advances in the biochemistry and pathophysiology of the peritoneal membranes.Kidney Int2002; 61: 375–86.
20.
KakutaT., TanakaR., SatohY., IzuharaY., InagiR., NangakuM.Pyridoxamine improves functional, structural, and biochemical alterations of peritoneal membranes in uremic PD rats.Kidney Int2005; 68: 1326–36.
